huangqi guizhi wuwu

Botanicalexperimental

Clinical trial activity

6 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
1

Earliest trial started Jan 1, 2020 (NCT05566457)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06074809Phase 2Nov 1, 2023Chinese University of Hong Kong
NCT05841901N/AJun 1, 2023Henan Medical University, Henan University of Traditional Chinese Medicine
NCT05418465N/AJan 26, 2022Dalian Medical University
NCT04690283Phase 3Jan 1, 2021Fudan University, Jiangsu Cancer Institute & Hospital, Nanjing Medical University, Nanjing NingQi Medicine Science and Technology Co., Ltd., Nanjing University
NCT04261920Phase 4Jan 3, 2020Guangzhou Pharmaceucal Company Limited
NCT05566457Phase 2Jan 1, 2020Chinese Academy of Medical Sciences
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chinese Academy of Medical SciencesAcademic/Hospital1112020
Chinese University of Hong KongAcademic/Hospital1112023
Dalian Medical UniversityAcademic/Hospital1112022
Fudan UniversityAcademic/Hospital1012021
Guangzhou Pharmaceucal Company LimitedFor profit1112020
Henan Medical UniversityAcademic/Hospital1012023
Henan University of Traditional Chinese MedicineAcademic/Hospital1112023
Jiangsu Cancer Institute & HospitalAcademic/Hospital1012021
Nanjing Medical UniversityAcademic/Hospital1012021
Nanjing NingQi Medicine Science and Technology Co., Ltd.Government1112021
Nanjing UniversityAcademic/Hospital1012021
11 organizations
Page 1 / 1